-
EU to ban plant-based 'bacon' but veggie 'burgers' survive chop
-
Leagues Cup to hold matches in Mexico for first time
-
India reach T20 World Cup final after England fail in epic chase
-
Conservative Anglicans press opposition to Church's first woman leader
-
Iran players sing anthem and salute at Women's Asian Cup
-
India beat England in high-scoring T20 World Cup semi-final
-
Mideast war traps 20,000 seafarers, 15,000 cruise passengers in Gulf
-
Italy bring back Brex to face England
-
French policeman to be tried over 2023 killing of teen
-
Oil prices rise, stocks slide as Middle East war stirs supply concerns
-
More flights take off despite continued fighting in Middle East
-
Ukraine, Russia free 200 POWs each
-
Middle East war halts work at WHO's Dubai emergency hub
-
Paramount's Ellison vows CNN editorial independence
-
US says attacks on alleged drug boats have spooked traffickers
-
Dempsey returns as Scotland shuffle pack for Six Nations clash against France
-
India pile up 253-7 against England in T20 World Cup semi-final
-
Wary Europeans pledge 'defensive' military aid in Mideast war
-
Seven countries to boycott Paralympics ceremony over Russia: organisers
-
UK's Crufts dog show opens with growing global appeal
-
PSG prepare for Chelsea clash with Monaco rematch
-
Google opens AI centre as Berlin defends US tech reliance
-
Second Iranian ship nears Sri Lanka after submarine attack
-
Portugal mourns acclaimed writer Antonio Lobo Antunes
-
Union loses fight against Tesla at German factory
-
Wales revel in being the underdogs, says skipper Lake
-
German school students rally against army recruitment drive
-
Wary European states pledge military aid for Cyprus, Gulf
-
Liverpool injuries frustrating Slot in tough season
-
Real Madrid will 'keep fighting' in title race, vows Arbeloa
-
Australia join South Korea in quarters of Women's Asian Cup
-
Kane to miss Bayern game against Gladbach with calf knock
-
Henman says Raducanu needs more physicality to rise up rankings
-
France recall fit-again Jalibert to face Scotland
-
Harry Styles fans head in one direction: to star's home village
-
Syrian jailed over stabbing at Berlin Holocaust memorial
-
Second Iranian ship heading to Sri Lanka after submarine attack
-
Middle East war spirals as Iran hits Kurds in Iraq
-
Norris hungrier than ever to defend Formula One world title
-
Fatherhood, sleep, T20 World Cup final: Henry's whirlwind journey
-
Conservative Nigerian city sees women drive rickshaw taxis
-
T20 World Cup hero Allen says New Zealand confidence high for final
-
The silent struggle of an anti-war woman in Russia
-
Iran hits Kurdish groups in Iraq as conflict widens
-
China sets lowest growth target in decades as consumption lags
-
Afghans rally against Pakistan and civilian casualties
-
South Korea beat Philippines 3-0 to reach women's quarter-finals
-
Mercedes' Russell not fazed by being tipped as pre-season favourite
-
Australia beat Taiwan in World Baseball Classic opener
-
Underdogs Wales could hurt Irish after Scotland display: Popham
Ozempic slimming craze sweeps Kosovo despite side effects
Kosovo influencer Tringa Kadriu sees the slimming drug Ozempic as a chance to shed excess pounds -- and she is not the only one in her Balkan nation, where more than half the population is overweight.
"I want to lose 15-16 kilos (33-35 pounds) in two months," Kadriu, 29, told AFP, "and then I'll continue with fitness".
Ozempic, approved in the United States to treat diabetes in 2017, has found an international market for people trying to lose weight.
Despite its cost, the drug has soared in popularity in Kosovo, a country of 1.7 million.
While Kosovo authorities have not sanctioned the drug's use for weight loss, they have noted their limited means to confront use of a drug widely available in the country.
Merita Emini-Sadiku, who heads the Kosovo university hospital's endocrinology clinic, said the cost of the drug had soared.
"The monthly dose used to be 75-80 euros ($85-91), while now it is 130-140 euros ($147-159), probably due to high demand," she said.
But she warned that "Ozempic has side effects that people are not aware of".
Ozempic use can potentially cause issues including thyroid cancer, pancreatitis, gastroparesis and bowel obstruction, according to the latest studies.
- 'Constant demand' -
Meant to treat Type 2 diabetes -- of which the WHO says Kosovo has lower than average levels -- the drug regulates blood sugar levels but also helps suppress hunger, leading to a lower calorie intake.
As a result, its potentially cancerous complications have done little to stem the drug's popularity or availability.
"I checked a lot of pharmacies in Kosovo and I noticed that Ozempic is very easy to get," said Kadriu, adding that pharmacists even suggested she gradually increase her dosage.
A worker at a pharmacy in the capital Pristina's downtown, who asked to remain anonymous, said she had trouble recalling when someone last came into her pharmacy to buy Ozempic with a diabetes prescription.
"But we have a constant demand for Ozempic without a prescription. You can guess why," she said.
Given its availability, Emini-Sadiku said authorities should exercise greater control over Ozempic's distribution.
But Bujar Vitija, a journalist specialising in health, said that would be tricky to achieve given Kosovo's poor health record-keeping.
"Unfortunately there is no data," Vitija said.
With 1,500 to 1,600 private pharmacies in Kosovo, the country's 20 pharmaceutical inspectors have their work cut out for them, he added.
- Ozempic 'every day' -
While Kosovo has lower levels of obesity than the European average, more than 57 percent of the population is overweight and 20 percent is clinically obese, according to a 2019 World Health Organization report.
And women, who are more likely to face societal pressure to be thin, were 66 percent more likely to be obese than men, the WHO report found.
But not every Kosovar who has used Ozempic had the best experience with the drug.
"I took Ozempic on the advice of a doctor for two years but it had no effect," said 48-year-old merchant Lulzim Rrahmani, adding that three of his relatives even experienced "a negative effect of the drug".
"It was just a waste of money and time."
Given the risk of side effects, Emini-Sadiku said Ozempic was "by no means to be taken without a doctor's prescription".
Yet Kadriu said she would not be deterred, adding that she saw colleagues taking the drug "every day at work".
"I don't see any symptom that would deter me."
N.Schaad--VB